Παρακολούθηση
Hara Georgatzakou
Hara Georgatzakou
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα biol.uoa.gr
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Glucose 6-phosphate dehydrogenase deficient subjects may be better “storers” than donors of red blood cells
VL Tzounakas, AG Kriebardis, HT Georgatzakou, ...
Free Radical Biology and Medicine 96, 152-165, 2016
1092016
Donor variation effect on red blood cell storage lesion: a multivariable, yet consistent, story
VL Tzounakas, HT Georgatzakou, AG Kriebardis, AI Voulgaridou, ...
Transfusion 56 (6), 1274-1286, 2016
942016
Uric acid variation among regular blood donors is indicative of red blood cell susceptibility to storage lesion markers: a new hypothesis tested
VL Tzounakas, HT Georgatzakou, AG Kriebardis, EG Papageorgiou, ...
Transfusion 55 (11), 2659-2671, 2015
592015
Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects
AG Kriebardis, MH Antonelou, HT Georgatzakou, VL Tzounakas, ...
Blood Transfusion 14 (3), 228, 2016
362016
Red blood cell abnormalities and the pathogenesis of anemia in end‐stage renal disease
HT Georgatzakou, MH Antonelou, IS Papassideri, AG Kriebardis
PROTEOMICS–Clinical Applications 10 (8), 778-790, 2016
342016
Red blood cell abnormalities as the mirror of SARS-CoV-2 disease severity: a pilot study
A Bouchla, AG Kriebardis, HT Georgatzakou, SP Fortis, K Markakis, ...
Frontiers in Physiology 12, 825055, 2022
312022
Donor‐specific individuality of red blood cell performance during storage is partly a function of serum uric acid levels
VL Tzounakas, DG Karadimas, AT Anastasiadi, HT Georgatzakou, ...
Transfusion 58 (1), 34-40, 2018
262018
Temperature-dependent haemolytic propensity of CPDA-1 stored red blood cells vs whole blood-Red cell fragility as donor signature on blood units
VL Tzounakas, AT Anastasiadi, DG Karadimas, RA Zeqo, ...
Blood Transfusion 15 (5), 447, 2017
262017
Blood cell-derived microvesicles in hematological diseases and beyond
HT Georgatzakou, SP Fortis, EG Papageorgiou, MH Antonelou, ...
Biomolecules 12 (6), 803, 2022
202022
Data on how several physiological parameters of stored red blood cells are similar in glucose 6-phosphate dehydrogenase deficient and sufficient donors
VL Tzounakas, AG Kriebardis, HT Georgatzakou, ...
Data in brief 8, 618-627, 2016
202016
Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study
MH Antonelou, HT Georgatzakou, VL Tzounakas, AD Velentzas, ...
Journal of proteomics 101, 88-101, 2014
192014
Coagulation abnormalities in renal pathology of chronic kidney disease: the interplay between blood cells and soluble factors
EG Pavlou, HT Georgatzakou, SP Fortis, KA Tsante, AG Tsantes, ...
Biomolecules 11 (9), 1309, 2021
162021
Pathophysiological aspects of red blood cells in end‐stage renal disease patients resistant to recombinant human erythropoietin therapy
HT Georgatzakou, VL Tzounakas, AG Kriebardis, AD Velentzas, ...
European journal of haematology 98 (6), 590-600, 2017
142017
Short-term effects of hemodiafiltration versus conventional hemodialysis on erythrocyte performance
HT Georgatzakou, VL Tzounakas, AG Kriebardis, AD Velentzas, ...
Canadian journal of physiology and pharmacology 96 (3), 249-257, 2018
132018
The multi-faced extracellular vesicles in the plasma of chronic kidney disease patients
HT Georgatzakou, EG Pavlou, EG Papageorgiou, IS Papassideri, ...
Frontiers in Cell and Developmental Biology 8, 227, 2020
102020
Redox status, procoagulant activity, and metabolome of fresh frozen plasma in glucose 6-phosphate dehydrogenase deficiency
VL Tzounakas, F Gevi, HT Georgatzakou, L Zolla, IS Papassideri, ...
Frontiers in Medicine 5, 16, 2018
72018
Haemostatic profile of riboflavin-treated apheresis platelet concentrates
E Petrou, GK Nikolopoulos, AG Kriebardis, K Pantavou, E Loukopoulou, ...
Blood Transfusion 20 (3), 223, 2022
52022
Effect of silica-based mesoporous nanomaterials on human blood cells
SP Fortis, A Batrinou, HT Georgatzakou, I Tsamesidis, G Alvanidis, ...
Chemico-Biological Interactions 387, 110784, 2024
32024
Economic crisis in Greece: The invisible enemy of blood donation or not?
SP Fortis, AG Kriebardis, HT Georgatzakou, G Lyrakos, P Alexiou, ...
Transfusion and Apheresis Science 61 (6), 103467, 2022
12022
“Valar morghulis”: all red cells must die
HT Georgatzakou, MH Antonelou, EG Papageorgiou, AG Kriebardis
Blood Transfusion 18 (2), 83, 2020
12020
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20